In GSE89632 dataset, with the highest number of participants (n = 63), IFI27 was significantly upregulated by 7% and 5.4% in steatosis and NASH, respectively, as compared with healthy individuals (normal) (adj. Here, IFI27 is linked to metabolic dysfunction-associated steatohepatitis.